In the current study, we further demonstrated that OLFM4 expression correlated with the differentiation of endometrial adenocarcinoma, and dysfunction of ER signalling-mediated OLFM4 expression promoted the malignant progression of the cancer, which may potentially have significance for the treatment of endometrial adenocarcinoma. Here, OLFM4 is linked to endometrium adenocarcinoma.